Cargando…
High Smad7 in the early post-operative recurrence of Crohn’s disease
BACKGROUND: In Crohn’s disease (CD), one of the major inflammatory bowel disease (IBD) in human beings, there is over-expression of Smad7, an intracellular inhibitor of the suppressive cytokine TGF-β1. The aim of this study was to assess whether Smad7 over-expression occurs in the early and/or late...
Autores principales: | Zorzi, Francesca, Calabrese, Emma, Di Fusco, Davide, De Cristofaro, Elena, Biancone, Livia, Casella, Sara, Palmieri, Giampiero, Monteleone, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574182/ https://www.ncbi.nlm.nih.gov/pubmed/33076905 http://dx.doi.org/10.1186/s12967-020-02558-8 |
Ejemplares similares
-
Distinct Profiles of Effector Cytokines Mark the Different Phases of Crohn’s Disease
por: Zorzi, Francesca, et al.
Publicado: (2013) -
A Pharmacological Batch of Mongersen that Downregulates Smad7 is Effective as Induction Therapy in Active Crohn’s Disease: A Phase II, Open-Label Study
por: Marafini, Irene, et al.
Publicado: (2021) -
Long-Term Outcomes and Predictive Factors of Hospitalized Patients with Severe Ulcerative Colitis Treated with Intravenous Corticosteroids
por: De Cristofaro, Elena, et al.
Publicado: (2021) -
Endoscopic Predictors of Neoplastic Lesions in Inflammatory Bowel Diseases Patients Undergoing Chromoendoscopy
por: Lolli, Elisabetta, et al.
Publicado: (2022) -
A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn’s Disease
por: Di Fusco, Davide, et al.
Publicado: (2020)